WebHere's Why You Should Add CRISPR Stock to Your Portfolio. Zacks. Mar-18-23 07:18PM: 3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time. InvestorPlace. 06:14AM: 3 … WebApr 14, 2024 · Zacks Equity Research. CRISPR Therapeutics AG CRSP shares soared 16.3% in the last trading session to close at $50.56. The move was backed by solid volume with far more shares changing hands than ...
Crispr Therapeutics AG (CRSP) Stock Price & News
WebStock analysis for CRISPR Therapeutics AG (CRSP:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. WebCRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. In fiscal year 2024, the company had revenues of $915 million, with net income of $378 million. By the end of the same year, the … together fcu
CRISPR Therapeutics AG (CRSP) Stock Price, News, Quote
WebApr 12, 2024 · The low in the last 52 weeks of CRISPR Therapeutics stock was 38.95. According to the current price, CRISPR Therapeutics is 111.60% away from the 52-week … Web1 day ago · CRSP has an average price target of $84.19 among all 26 analysts with coverage of the stock. That implies an upside of about 68%. However, insider activity … WebApr 12, 2024 · CRISPR Therapeutics Stock Forecast and Price Target The average price target for CRISPR Therapeutics's stock lately set by several renowned analysts is $150.00, which would result in a potential upside of approximately 269% if it reaches this mark by December 31, 2024. together fees